CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 27 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2 | +100.0% | 1 | 0.0% | 0.00% | – |
| Q2 2023 | $1 | -50.0% | 1 | 0.0% | 0.00% | – |
| Q1 2023 | $2 | 0.0% | 1 | 0.0% | 0.00% | – |
| Q4 2022 | $2 | – | 1 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | – | 1 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 896,170 | $4,615,000 | 3.22% |
| Ariel Investments | 1,010,220 | $5,203,000 | 0.06% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 183,000 | $942,000 | 0.01% |
| Anfield Capital Management, LLC | 4,530 | $23,000 | 0.01% |
| Financial Gravity Asset Management, Inc. | 2,000 | $10,000 | 0.01% |
| Oakworth Capital, Inc. | 3,052 | $16,000 | 0.00% |
| BAILARD, INC. | 11,816 | $61,000 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 860,319 | $4,431,000 | 0.00% |
| Renaissance Technologies | 469,338 | $2,417,000 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 98,192 | $506,000 | 0.00% |